Enfusion Results Presentation Deck

Q4 2022 key financial highlights $ in millions Highly attractive SaaS model with combination of scale, growth and profitability *:enfusion Total Revenue Gross Profit Adjusted Gross Profit Net Income Adjusted EBITDA (1) Operating Cash Flow (1) Adjusted Free Cash Flow (1) (1) See appendix for definition and non-GAAP reconciliations. $40.5 $27.2 $27.5 $0.8 $6.8 $7.5 $3.6 PROPRIETARY AND CONFIDENTIAL 27.2% YOY Growth 67.2% 68.0% Adjusted Gross Margin 1.9% Net income Margin 16.7% Adjusted EBITDA Margin 18.6% OCF Margin 53.4% FCF Conversion ©2023 ENFUSION. ALL RIGHTS RESERVED. 10

View entire presentation